(+)-Eburnamenine-14-carboxylic acid (2-nitroxyethyl) ester (VA-045), a putative cognitive enhancer, facilitates recovery from concussive brain injury-induced learning and memory impairments in mice

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 195-199

  Tang, Ya Ping ^a   Noda, Yukihiro ^a   Hasegawa, Takaaki ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anterograde amnesia; concussive brain injury (CBI); latent learning; retention; retrieval; retrograde amnesia; VA 045

Indexed keywords

EBURNAMENINE 14 CARBOXYLIC ACID (2 NITROXYETHYL) ESTER; NOOTROPIC AGENT; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN CONCUSSION; CONFERENCE PAPER; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031081047     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86068-8     Document Type: Conference Paper

References (32)

1. [1] Alberini, C.M., Ghirardi, M., Metz, R. and Kandel, E.R., C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia, Cell, 76 (1994) 1099-1114.
2. [2] Cortez, S.C., McIntosh, T.K. and Noble, L.J., Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations, Brain Res., 482 (1989) 271-282.
3. [3] Faden, A.I., Demediup, P., Panter, S.S. and Vink, R., The role of excitatory amino acid receptors and NMDA receptors in traumatic brain injury, Science, 244 (1989) 798-800.
4. 45Ca autoradiographic study, Brain Res., 624 (1993) 94-102.
5. [5] Gabriel, H.I., Approaches to the analysis of the neural bases of memory. In: Memory, Imprinting, and the Brain: Inquiry into Mechanisms, Oxford Psychology Series No. 1, Clarendon Press, Oxford, 1985, pp. 1-28.
6. [6] Gorman, L.K., Shook, B.L. and Becker, D.P., Traumatic brain injury produces impairments in long-term and recent memory, Brain Res., 614 (1993) 29-36.
7. 2+ channels: effects of bifemelane and several nootropic agents, Eur. J. Pharmacol, 189 (1990) 51-58.
8. [8] Kawashima, Y., Ikemoto, T., Horiguchi, A., Hayashi, M., Matsmoto, K., Kawarasaki, K., Yamazaki, R., Okuyama, S. and Hatayama, K., Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates, J. Med. Chem., 36 (1993) 815-819.
9. [9] Kiss, B., Cai, N.S. and Erdo, S.L., Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies, Eur. J. Pharmacol., 209 (1991) 109-112.
10. [10] Lowenstein, D.H., Thomas, M.J., Smith, D.H. and McIntosh, T.K., Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus, J. Neurosci., 12 (1992) 4846-4853.
11. [11] Lyeth, B.G., Dixon, C.E., Hamm, R.J., Jenkins, L.W., Young, H.F., Stonnington, H.H. and Hayes, R.L., Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat, Brain Res., 448 (1988) 88-97.
12. [12] Lyeth, B.G., Dixon, C.E., Jenkins, L.W., Hamm, R.J., Alberico, A., Young H.F., Stonnington, H.H. and Hayes, R.L., Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat, Brain Res., 452 (1988) 39-48.
13. 2+ dependence, Eur. J. Pharmacol., 162 (1989) 387-395.
14. [14] Marmarrou, A., Foda, M.A.A., Brink, W.V.D., Kita, J.C.H. and Demetriadou, K., A new model of diffuse brain injury in rats, Part I: Pathophysiology and biomechanics, J. Neurosurg., 80 (1994) 291-300.
15. [15] Matzel, L.D., Collin, C. and Alkon, D.L., Biophysical and behavioral correlates of memory storage, degradation, and reactivation, Behav. Neurosci., 106 (1992) 954-963.
16. [16] McGaugh, J.L., Time-dependent processes in memory storage, Science, 153 (1966) 1351-1358.
17. [17] McGurk, S.R., Levin, E.D. and Butcher, L.L., Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway, Neuroscience, 50 (1992) 129-135.
18. [18] Metzger, D., Alescio-lautier, B., Bosler, O., Devigen, C. and Soumireu-mourat, B., Effects of changes in the intrahippocampal vasopression on memory retrieval and relearning, Behav. Neural Biol., 59 (1993) 29-48.
19. [19] Miskolczi, P., Kozma, K., Polgar, M. and Vereczkey, L., Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans, Eur. J. Drug Metab. Pharmacokinet., 15 (1990) 1-5.
20. 2+ channels, Biochem. Pharmacol., 42 (1991) 190-192.
21. [21] Nabeshima, T. and Ichihara, K., Measurements of dissociation of amnesiac and behavioral effects of drugs in mice. In: P.M. Conn (Ed.), Methods in Neurosciences, Vol. 14, Academic Press, San Diego, 1993, pp. 217-229.
22. [22] Okuyama, S., Imagawa, Y., Ogawa, S.-I., Araki H., Otomo, S., Sakagawa, T., Yamada, S. and Shima, K., Effects of VA-045 on a closed head injury model in rats, Life Sci., 53 (1993) 273-278.
23. [23] Okuyama, S., Imagawa, Y., Ogawa, S.-I., Saito, Y., Araki, H., Otomo, S., Sakagawa, T., Yamada, S. and Shima, K., The effect of VA-045 on disturbance in consciousness in experimental animal models, Res. Commun. Chem. Pathol. Pharmacol., 82 (1993) 91-100.
24. [24] Packard, M.G. and White, N.M., Dissociation of hippocampus and caudate nucleus memory systems by post-training intracerebral injections of dopamine agonists, Behav. Neurosci., 105 (1991) 295-306.
25. [25] Pierce, J.E.S., Smith, D.H., Eison, M.S. and Miintosh, T.K., The nootropic compound BMY-21502 improves spatial learning ability in brain injured rats, Brain Res., 624 (1993) 199-208.
26. [26] Rimel, R.W., Giordani, B., Barth, J. and Jane, J.A., Moderate head injury: completing the clinical spectrum of brain injury, Neurosurgery, 11 (1982) 344-351.
27. [27] Rischke, R. and Krieglstein, J., Protective effect of vinpocetine against brain damage caused by ischemia, Jpn. J. Pharmacol., 56 (1991) 349-356.
28. [28] Rutherford, W.H., Merrett, J.D. and Mcdorald, J.R., Sequelae of concussive caused by minor head injury, Lancet, 1 (1977) 1-4.
29. [29] Smith, D.H., Okiyama, K., Gennarelli, T.A. and McIntosh, T.K., Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury, Neurosci. Lett., 157 (1993) 211-214.
30. [30] Squire, L.R., Mechanisms of memory, Science, 232 (1986) 1612-1619.
31. [31] Squire, L.R. and Cohen, N.J., Human memory and amnesia. In: G. Lynch (Ed.), Neurobiology of Learning and Memory, Guilford Press, New York, 1984, pp. 3-64.
32. [32] Yamamoto, M. and Shimizu, M., Effects of a new TRH analogue, YM-14673 on the central nervous system, Naunyn-Schmiedberg's Arch. Pharmacol., 336 (1987) 511-515.